Aberdare Gp Iii, L.l.c. - Net Worth and Insider Trading
Aberdare Gp Iii, L.l.c. Net Worth
The estimated net worth of Aberdare Gp Iii, L.l.c. is at least $1 Million dollars as of 2025-01-01. Aberdare Gp Iii, L.l.c. is the 10% Owner of Conatus Pharmaceuticals Inc and owns about 2,279,363 shares of Conatus Pharmaceuticals Inc (CNAT) stock worth over $1 Million. Details can be seen in Aberdare Gp Iii, L.l.c.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Aberdare Gp Iii, L.l.c. has not made any transactions after 2013-07-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Aberdare Gp Iii, L.l.c.
Aberdare Gp Iii, L.l.c. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Aberdare Gp Iii, L.l.c. owns 1 companies in total, including Histogen Inc (HSTOQ) .
Click here to see the complete history of Aberdare Gp Iii, L.l.c.’s form 4 insider trades.
Insider Ownership Summary of Aberdare Gp Iii, L.l.c.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HSTOQ | Histogen Inc | 2013-07-24 | 10 percent owner |
Aberdare Gp Iii, L.l.c. Latest Holdings Summary
Aberdare Gp Iii, L.l.c. currently owns a total of 1 stock. Aberdare Gp Iii, L.l.c. owns 2,279,363 shares of Conatus Pharmaceuticals Inc (CNAT) as of July 30, 2013, with a value of $1 Million.
Latest Holdings of Aberdare Gp Iii, L.l.c.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CNAT | Conatus Pharmaceuticals Inc | 2013-07-30 | 2,279,363 | 0.56 | 1,276,443 |
Holding Weightings of Aberdare Gp Iii, L.l.c.
Aberdare Gp Iii, L.l.c. Form 4 Trading Tracker
According to the SEC Form 4 filings, Aberdare Gp Iii, L.l.c. has made a total of 0 transactions in Conatus Pharmaceuticals Inc (CNAT) over the past 5 years. The most-recent trade in Conatus Pharmaceuticals Inc is the sale of 566 shares on July 30, 2013, which brought Aberdare Gp Iii, L.l.c. around $6,226.
Insider Trading History of Aberdare Gp Iii, L.l.c.
- 1
Aberdare Gp Iii, L.l.c. Trading Performance
Aberdare Gp Iii, L.l.c. Ownership Network
Aberdare Gp Iii, L.l.c. Owned Company Details
What does Histogen Inc do?
Who are the key executives at Histogen Inc?
Aberdare Gp Iii, L.l.c. is the 10 percent owner of Histogen Inc. Other key executives at Histogen Inc include See Remarks Joyce Reyes , director & See Remarks Richard W Pascoe , and See Remarks Moya Daniels .
Histogen Inc (HSTOQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Histogen Inc (HSTOQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Histogen Inc (HSTOQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Histogen Inc (HSTOQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Histogen Inc Insider Transactions
Aberdare Gp Iii, L.l.c. Mailing Address
Above is the net worth, insider trading, and ownership report for Aberdare Gp Iii, L.l.c.. You might contact Aberdare Gp Iii, L.l.c. via mailing address: One Embarcadero Center, Suite 4000, San Francisco Ca 94111.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
